The Ruesch Center

The Ruesch Center and Medscape collaborate to cover topics essential to the practicing clinician who has an interest in gastrointestinal cancers -- by providing information on emerging treatments, practice standards, and individualized patient care.

• Colon Cancer in Young People: Not an Obesity Issue   John L. Marshall, MD, discusses colon cancer in young people.
  Medscape Oncology, April 2023
• No-Visitor Policies Are Bad Medicine   Hospitals during the pandemic are the 'loneliest place on Earth.' Oncologist John Marshall explains why patients -- and providers -- benefit from the presence of visitors.
  Medscape Oncology, August 2020
• COVID-19 Has Strengthened Pharma's Negotiating Hand   Dr John Marshall discusses the impact of COVID-19 on discussions related to drug prices.
  Medscape Oncology, July 2020

More

• Why the High CRC Rate in Latino--Genes, Stigma, or Other Factors?   Colorectal cancer is the second most common cause of cancer death in the Latino population. Drs John Marshall and Marcia Cruz-Correa discuss which factors are at play.
  Ruesch Center, March 20, 2017
• Colorectal Cancer in Young Adults: An 'Issue Screaming for Action'   Dr John Marshall speaks to Dr Thomas Weber about the increasing incidence of colorectal cancer in young adults and simple steps that clinicians can take to slow this disturbing trend.
  Ruesch Center, January 30, 2017
• Oncology and Politics: How Long Will the Honeymoon Last? A commentary on Joe Biden's Moonshot address at ASCO and what it will really take to make the initiative successful.
  Ruesch Center, June 27, 2016
• Tumor 'Profiling' Takes on New Significance in GI Cancer Dr Brandon Smaglo reviews key GI cancer presentations from ASCO 2016, finding that growing refinement of tumor subtyping is key to matching patients with effective treatments, including immunotherapy.
  Ruesch Center, June 14, 2016
• 'Releasing the Dogs’ in the Body’s War on Cancer   Drs Lou Weiner and Chris Heery vividly describe strategies that prompt the immune system to attack and kill cancer cells, and offer a view from the trenches of cancer immunotherapy.
  Ruesch Center, February 18, 2016

More